A patently ambitious man
Saturday, 21 June 2008
Amy Yee in New Delhi
At just 35, Malvinder Mohan Singh is one of the youngest of India's crop of ambitious business leaders. Known for his aggressive management style, Mr Singh has spearheaded 14 acquisitions in Europe, the US and India in recent years to extend Ranbaxy's reach and to beef up its drugs portfolio.
He is also infamous for launching aggressive litigation against the world's biggest drug makers to invalidate patents in order to give the Indian generic drug maker a head start in duplicating lucrative medicines.
Mr Singh and his brother Shivinder Mohan Singh have grown Ranbaxy, which was founded by their grandfather Bhai Mohan Singh, into an international producer of generic drugs.
The company, which vies with Indian rivals Dr Reddy's and Cipla, has manufacturing operations in 11 countries and sells its medicines in 125 countries. Ranbaxy, which has its headquarters in New Delhi, has also recently forged research partnerships with Merck and GlaxoSmithKline.
Mr Singh took the helm of Ranbaxy in 2006 and ranks among India's wealthiest people.
He has an MBA from Duke University and an undergraduate degree in economics from St Stephen's College in New Delhi.
At just 35, Malvinder Mohan Singh is one of the youngest of India's crop of ambitious business leaders. Known for his aggressive management style, Mr Singh has spearheaded 14 acquisitions in Europe, the US and India in recent years to extend Ranbaxy's reach and to beef up its drugs portfolio.
He is also infamous for launching aggressive litigation against the world's biggest drug makers to invalidate patents in order to give the Indian generic drug maker a head start in duplicating lucrative medicines.
Mr Singh and his brother Shivinder Mohan Singh have grown Ranbaxy, which was founded by their grandfather Bhai Mohan Singh, into an international producer of generic drugs.
The company, which vies with Indian rivals Dr Reddy's and Cipla, has manufacturing operations in 11 countries and sells its medicines in 125 countries. Ranbaxy, which has its headquarters in New Delhi, has also recently forged research partnerships with Merck and GlaxoSmithKline.
Mr Singh took the helm of Ranbaxy in 2006 and ranks among India's wealthiest people.
He has an MBA from Duke University and an undergraduate degree in economics from St Stephen's College in New Delhi.